Going All In
David discusses the potential for growth in the market, suggesting that current stock prices may not be overpriced. Jason prompts a deeper look into historical performance metrics, while David reveals his bold decision to step into the CEO role of a promising agricultural venture. With significant breakthroughs in gene editing, he feels compelled to fully commit, emphasizing the transformative potential of their work.In this clip
From this podcast
All-In Podcast
E156: Ivy League antisemitism, macro, SaaS recovery, Gemini, Figma deal delay + big Friedberg update
Related Questions